HKPD NASDAQ
Cellyan Biotechnology Co., Ltd
1W: -2.1%
1M: -28.0%
3M: -76.4%
YTD: -86.4%
1Y: -92.4%
$0.11
-0.00 (-2.06%)
Weekly Expected Move ±10.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$13M
+36.4% ▲
3Y CAGR: +55.6%
Total Liabilities
$3M
-26.3% ▼
3Y CAGR: +4.9%
Shareholders Equity
$10M
+92.1% ▲
3Y CAGR: +153.9%
Cash & Investments
$222K
-92.6% ▼
3Y CAGR: -24.9%
Total Debt
$1M
-47.0% ▼
3Y CAGR: +22.1%
Net Debt
$1M
-36.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| — Assets — | ||||
| Cash | $525K | $620K | $749K | $222K |
| Short-Term Investments | $0 | $0 | $2M | $0 |
| Cash & ST Investments | $525K | $620K | $3M | $222K |
| Net Receivables | $2M | $4M | $5M | $4M |
| Inventory | $191K | $933K | $560K | $360K |
| Other Current Assets | $269K | $1M | $400 | $2M |
| Total Current Assets | $3M | $8M | $9M | $12M |
| Property, Plant & Equip. | $654K | $834K | $594K | $434K |
| Goodwill & Intangibles | $4K | $32K | $96K | $77K |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $658K | $866K | $690K | $511K |
| Total Assets | $3M | $9M | $9M | $13M |
| — Liabilities — | ||||
| Accounts Payable | $1M | $1M | $2M | $2M |
| Short-Term Debt | $62K | $215K | $372K | $878K |
| Deferred Revenue | $268K | $191K | $125K | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $464K |
| Total Current Liabilities | $3M | $3M | $3M | $3M |
| Long-Term Debt | $117K | $1M | $2M | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $271K | $1M | $2M | $65K |
| Total Liabilities | $3M | $4M | $4M | $3M |
| — Equity — | ||||
| Common Stock | $7K | $10K | $11K | $24K |
| Retained Earnings | $201K | $2M | $2M | $368K |
| Accumulated OCI | -$4K | -$5K | $11K | $240K |
| Total Stockholders Equity | $585K | $4M | $5M | $10M |
| Total Liabilities & Equity | $3M | $9M | $9M | $13M |
| — Key Metrics — | ||||
| Total Debt | $691K | $2M | $2M | $1M |
| Net Debt | $166K | $1M | $2M | $1M |
| Total Investments | $0 | $0 | $2M | $0 |